Herbal Anti-inflammatory composition
A polyherbal composition of Nigella sativa, Tinospora cordifolia, Petasites hybridus, and Perilla frutescens extracts addresses the limitations of synthetic treatments by offering enhanced anti-inflammatory effects with reduced side effects and lower concentration requirements.
Patent Information
- Application Number
- AU2023316885
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-07-29
- Filing Date
- 2023-07-29
- Publication Date
- 2026-07-16
AI Technical Summary
Existing treatments for inflammation, such as those using synthetic compounds, often cause side effects like drowsiness and acid reflux, and there is a lack of effective compositions combining Nigella sativa, Tinospora cordifolia, Petasites hybridus, and Perilla frutescens for treating inflammation.
A polyherbal anti-inflammatory composition comprising a mixture of water extracts from Nigella sativa, Tinospora cordifolia, Petasites hybridus, and Perilla frutescens, formulated into suitable dosage forms, providing synergistic anti-inflammatory effects at lower concentrations than individual components.
The polyherbal extract demonstrates superior anti-inflammatory activity, inhibiting protein denaturation more effectively than individual herbs or standard drugs, with reduced side effects and improved safety.